Join NETRF’s ‘Research Changes Lives’ Giving Tuesday Campaign—Every gift doubled now through December 3, 2024. LEARN MORE

Search

A campaign for the Neuroendocrine Tumor Research Foundation

Discovery

Accelerated the search for cures
Expand innovative research for breakthrough discoveries

Progress

More treatment options
Better quality of life

Awareness

Supported patient and families with information and education

Million in gifts to Spark Hope campaign
$ 0 M
To goal!!
25 %

100% 

Match on all gifts

What Your Donation Sparked

The Neuroendocrine Tumor Research Foundation has invested more than $30 million in research to increase our understanding of neuroendocrine tumors and develop insights to improve treatments.

Funding basic, translational and clinical research at leading institutions around the world.

Attracting the most influential, global scientists to advance our understanding and recruiting new researchers to NETs

Supporting team science to harness broad a range of perspectives in solving fundamental scientific questions

Leveraging revolutionary advances in biotechnology, molecular profiling and bioengineering.

Providing educational conferences across the U.S. for patients and caregivers while posting videos of these talks on our website for viewing anytime

Want to discuss a special gift?

NETRF CEO Elyse Gellerman

Elyse Gellerman

Chief Executive Officer – 617.946.1783

Hear NET physicians and doctors discuss why funding is needed 

Your gifts helped improve, extend, and save lives

Every Gift Was Matched

The Spark Hope campaign was fueled by a generous match by the Margie and Robert E. Petersen Foundation. Every gift was doubled.

TESTIMONIALS

What Our Donors Are Saying

“I give to NETRF because my wife was diagnosed 20 years ago. And I want to accomplish what any husband would is to have an effective treatment and a cure for my wife’s disease. And we have seen remarkable progress made. But we will only get to a cure if we all work together and do whatever it takes.”

“I financially support NETRF because as an orphan disease there is not enough government funding and visibility from major foundations. So it is going to take a lot of other  donors to make research move forward.” 

Joe Li, MD
Chair NETRF Board of Directors

Todd Gilman
NETRF Board of Directors